NORMAL SITUATION

studio Pamaje

Financial year 2024 · closed on 31/12/2024
Net result
-1,2 k €
+69.9% YoY
Gross margin
-1 k €
+71.1% YoY
Equity
15,3 k €
-7.1% YoY

Company — Normal situation.

What does studio Pamaje do?

studio Pamaje is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0404.755.660
Legal form
Private limited company
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Signals
Solid equityGood liquidity
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 17 financial years

20242023202220212018201720162015201420132012201120102009200820072006
Income statement
Gross margin-1 k €-3,6 k €-9,3 k €-613 €-5,9 k €-13,2 k €239,2 k €-7 k €-4,5 k €1,5 k €2,2 k €697,4 €-1,9 k €1,5 k €-2,3 k €2,9 k €8,7 k €
EBITDA-1,6 k €-4,1 k €-9,8 k €-1,1 k €-6,3 k €-29 k €233,6 k €-10 k €-5,7 k €1,1 k €1,8 k €524,2 €-3,2 k €1,1 k €-2,7 k €2,6 k €8,3 k €
Operating result-1,6 k €-4,1 k €-9,8 k €-1,1 k €-19,1 k €-41,5 k €233,6 k €-23,2 k €-8,9 k €-2,2 k €-2,7 k €-4,1 k €-8,6 k €-4,6 k €-8,4 k €-2,7 k €2,9 k €
Net result-1,2 k €-3,9 k €-9,7 k €-252,1 €-22 k €-42,4 k €225,3 k €-25,1 k €-9 k €-3,2 k €-3,7 k €-6,2 k €-8,7 k €-7,8 k €-12,9 k €-7,3 k €-1,5 k €
Balance sheet
Equity15,3 k €16,5 k €20,4 k €30,1 k €-35,7 k €-13,7 k €28,7 k €-92,6 k €-67,5 k €-58,6 k €-55,3 k €-51,7 k €-45,5 k €-36,8 k €-29 k €-16,1 k €-8,8 k €
Total assets15,7 k €16,5 k €21,6 k €53,7 k €194,5 k €148 k €147 k €40,2 k €52,1 k €64,8 k €67,1 k €74,6 k €77,2 k €89,2 k €93 k €95,2 k €97,4 k €
Cash202,4 €214,7 €3,9 k €53,7 k €22,4 k €5,6 k €90,2 k €1,9 k €3,7 k €4,8 k €3,7 k €4,2 k €2,9 k €3,2 k €697,2 €
Debts421,9 €34,6 €1,3 k €23,6 k €230,1 k €161,6 k €118,3 k €132,7 k €119,6 k €123,4 k €122,5 k €126,3 k €122,7 k €125,3 k €121,9 k €111,2 k €106,1 k €
Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 8 ended

Active mandates

VASCO PHARMA

Director · 0870.190.760

Represented by Marleen Nijs

Active

Ended mandates

VASCO PHARMA

Manager · since 01 juillet 2016 · 0870.190.760

Represented by Marleen Nijs

Ended
Marc De Roeck

Manager · since 31 décembre 2014

Ended
Herman Nelis

Manager · until 31 décembre 2014

Ended
Herman Nelis

Manager

Ended
Annual accounts

Full financial information

202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date25/07/202530/07/202403/08/202311/10/202212/07/202111/08/2020
General meeting27/06/202528/06/202430/06/202330/06/202230/06/202130/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

47 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202427/06/202525/07/2025DutchPDF
Abridged model31/12/202328/06/202430/07/2024DutchPDF
Abridged model31/12/202230/06/202303/08/2023DutchPDF
Abridged model31/12/202130/06/202211/10/2022DutchPDF
Abridged model31/12/202030/06/202112/07/2021DutchPDF
Abridged model31/12/201930/06/202011/08/2020DutchPDF
Abridged model31/12/201830/06/201916/07/2019DutchPDF
Abridged model31/12/201730/06/201801/10/2018FrenchPDF
Micro model31/12/201630/06/201714/07/2017FrenchPDF
Abridged model31/12/201517/06/201615/07/2016FrenchPDF
Abridged model31/12/201430/06/201523/07/2015DutchPDF
Abridged model31/12/201325/06/201416/07/2014DutchPDF
Abridged model31/12/201225/06/201310/07/2013DutchPDF
Abridged model31/12/201125/06/201219/07/2012DutchPDF
Abridged model31/12/201025/06/201125/07/2011DutchPDF
Abridged model31/12/200925/06/201020/07/2010DutchPDF
Abridged model31/12/200825/06/200917/07/2009DutchPDF
Abridged model31/12/200725/06/200818/07/2008DutchPDF
Abridged model31/12/200625/06/200719/07/2007DutchPDF
Abridged model31/12/200525/06/200614/07/2006DutchPDF
Abridged model31/12/200425/05/200520/06/2005DutchPDF
Abridged model31/12/200325/05/200403/06/2004DutchPDF
Abridged model31/12/200225/05/200324/06/2003DutchPDF
Abridged model31/12/200125/05/200212/06/2002DutchPDF

View all 47 filings

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 8 ended

Active mandates

VASCO PHARMA

Director · 0870.190.760

Represented by Marleen Nijs

Active

Ended mandates

VASCO PHARMA

Manager · since 01 juillet 2016 · 0870.190.760

Represented by Marleen Nijs

Ended
Marc De Roeck

Manager · since 31 décembre 2014

Ended
Herman Nelis

Manager · until 31 décembre 2014

Ended
Herman Nelis

Manager

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Dissolution18/12/2025
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-1,2 k €
  2. 2023
    Annual accounts 2023-3,9 k €
  3. 2022
    Annual accounts 2022-9,7 k €
  4. 2021
    Annual accounts 2021-252,1 €
  5. 2018
    Annual accounts 2018-22 k €
  6. 2017
    Annual accounts 2017-42,4 k €
  7. 2016
    Annual accounts 2016225,3 k €
  8. 2015
    Annual accounts 2015-25,1 k €
  9. 2014
    Annual accounts 2014-9 k €
  10. 2013
    Annual accounts 2013-3,2 k €
  11. 2012
    Annual accounts 2012-3,7 k €
  12. 2011
    Annual accounts 2011-6,2 k €
  13. 2010
    Annual accounts 2010-8,7 k €
  14. 2009
    Annual accounts 2009-7,8 k €
  15. 2008
    Annual accounts 2008-12,9 k €
  16. 2007
    Annual accounts 2007-7,3 k €
  17. 2006
    Annual accounts 2006-1,5 k €